Propanc Biopharma Receives Orphan Drug Designation from...

2017-06-26T17:20:38-07:00

Propanc Biopharma Receives Orphan Drug Designation from FDA for Treatment of Pancreatic Cancer MELBOURNE, AUSTRALIA--(Marketwired - June 27, 2017) - Propanc Biopharma Inc. (PPCB), a clinical stage biopharmaceutical company focusing on ...

Propanc Biopharma Receives Orphan Drug Designation from...2017-06-26T17:20:38-07:00

FDA weighs crackdown that could shut hundreds of...

2016-09-09T09:29:44-07:00

Scientists on Monday will urge the Food and Drug Administration to crack down on rogue clinics across the country that market stem cell treatments for a dizzying array of ailments ...

FDA weighs crackdown that could shut hundreds of...2016-09-09T09:29:44-07:00

STOCKWATCHINDEX © 2023 | ALL RIGHTS RESERVED | LEGAL | TERMS OF USE | PRIVACY POLICY

Go to Top